Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about ...
GlycoMimetics (GLYC) announced the Phase 2 analysis of the adaptive Phase 2/3 study of uproleselan being conducted by the National Cancer ...
The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback